Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2025-10-07 00:00:00 ET · period of report 2025-10-03 · accession 0001578850-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-10-07 | 2025-10-03 | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | M - OptEx | $30.86 | +55.0K | 152.2K | +57% | +$1.70M |
| DM | 2025-10-07 | 2025-10-03 | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | S - Sale+OE | $66.05 | -55.0K | 100.6K | -35% | -$3.63M |
| DM | 2025-10-07 | 2025-10-03 | PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS Off | M - OptEx | $0.00 | -55.0K | 51.6K | -52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-03 | M | A | 3,442 | $30.86 | 104,067 | D | — | — | (F2) Includes 272 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2025. |
| 2 | Common | Common Stock | 2025-10-03 | S | D | 1,609 | $65.46 | 102,458 | D | — | — | (F3) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $65.00 to $65.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2025-10-03 | S | D | 1,760 | $66.56 | 100,698 | D | — | — | (F4) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $66.15 to $67.03 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2025-10-03 | S | D | 4,276 | $67.15 | 100,625 | D | — | — | (F7) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $67.00 to $67.33 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2025-10-03 | M | A | 51,558 | $30.86 | 152,183 | D | — | — | |
| 6 | Common | Common Stock | 2025-10-03 | S | D | 23,419 | $65.45 | 128,764 | D | — | — | (F5) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $65.00 to $65.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2025-10-03 | S | D | 23,863 | $66.45 | 104,901 | D | — | — | (F6) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $66.00 to $66.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 8 | Common | Common Stock | 2025-10-03 | S | D | 73 | $67.16 | 100,625 | D | — | — | |
| 9 | Derivative | Stock Option (Right to Buy) | 2025-10-03 | M | D | 51,558 | $0.00 | 0 | D | $30.86 · — to 2026-01-03 | 51,558 Common Stock | (F8) Currently exercisable. |
| 10 | Derivative | Stock Option (Right to Buy) | 2025-10-03 | M | D | 3,442 | $0.00 | 51,558 | D | $30.86 · — to 2026-01-03 | 3,442 Common Stock | (F8) Currently exercisable. |